New approaches in identifying drugs to inactivate oncogene products

Seminars in Cancer Biology

Volumn 14, Issue 1, 2004, Pages 13-21

  Liu, Ruiwu ^a   Hsieh, Ching Yi ^a   Lam, Kit S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer therapeutic targets; Chemical microarrays; Combinatorial chemistry; Drug discovery; Inactivate oncogenes

Indexed keywords

BINDING AFFINITY; CANCER CELL DESTRUCTION; CELL ONCOGENE; COMBINATORIAL CHEMISTRY; CRYSTAL STRUCTURE; DNA MICROARRAY; DRUG DESIGN; DRUG INDUSTRY; DRUG SCREENING; DRUG TARGETING; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; GENETIC DATABASE; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PHAGE DISPLAY; PROTEIN MICROARRAY; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; X RAY ANALYSIS;

EID: 0742269699     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2003.11.003     Document Type: Article

References (94)

1. Atkins J.H., Gershell L.J. Selective anticancer drugs. Nat. Rev. Drug Discov. 1:2002;491-492.
2. Nicholson K.M., Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 14:2002;381-395.
3. Lutz M., Knaus P. Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal. 14:2002;977-988.
4. Osada H., Takahashi T. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene. 21:2002;7421-7434.
5. Balmain A. The genetics and genomics of cancer. Nat. Genet. 33(Suppl.):2003;238-244.
6. Klagsbrun M., Moses M.A. Molecular angiogenesis. Chem. Biol. 6:1999;R217-R224.
7. Singh S., Barrett J., Sakata K., Tozer R.G., Singh G. ETS proteins and MMPs: partners in invasion and metastasis. Curr. Drug Targets. 3:2002;359-367.
8. Kumar M., Carmichael G.G. Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. Microbiol. Mol. Biol. Rev. 62:1998;1415-1434.
9. Kittler R., Buchholz F. RNA interference: gene silencing in the fast lane. Semin. Cancer Biol. 13:2003;259-265.
10. Paddison P.J., Hannon G.J. siRNAs and shRNAs: skeleton keys to the human genome. Curr. Opin. Mol. Ther. 5:2003;217-224.
11. Denli A.M., Hannon G.J. RNAi: an ever-growing puzzle. Trends Biochem. Sci. 28:2003;196-201.
12. Tornell J., Snaith M. Transgenic systems in drug discovery: from target identification to humanized mice. Drug Discov. Today. 7:2002;461-470.
13. Lam K.S., Lebl M., Krchnak V. The "one-bead-one-compound" combinatorial library method. Chem. Rev. 97:1997;411-448.
14. Tiebes D. Combinatorial chemistry. In: Jung G, editor. Combinatorial chemistry. Weinheim: Wiley-VCH; 1999. p. 1-34.
15. Antonenko VV, Mortezaei R, Kulikov NV. Combinatorial chemistry. Methods Princ Med Chem (New Trends Synth Med Chem) 2000:7;39-80.
16. Weber L. Developments in combinatorial chemistry. Pharm Manuf Int 2000;45-6,48,50.
17. Appell K, Baldwin JJ, Egan WJ. Combinatorial chemistry and high-throughput screening in drug discovery and development. Handbook of modern pharmaceutical analysis, San Diego, CA, USA. Sep Sci Technol 2001;3:23-56.
18. Veselovsky A.V., Ivanov A.S. Strategy of computer-aided drug design. Curr. Drug Targets: Infect. Disord. 3:2003;33-40.
19. Sotriffer C., Klebe G. Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design. Farmaco. 57:2002;243-251.
20. Buchanan S.G. Structural genomics: bridging functional genomics and structure-based drug design. Curr. Opin. Drug Discov. Dev. 5:2002;367-381.
21. Reddy MR, Appelt K. HIV-1 protease: structure-based drug design using the free energy perturbation approach. Free Energy Calc Rational Drug Design 2001;1:317-34.
22. Shapiro M.J. Affinity NMR: a powerful method for drug discovery. Am. Pharm. Rev. 5:2002;96-97.
23. Kelly M.A., McLellan T.J., Rosner P.J. Strategic use of affinity-based mass spectrometry techniques in the drug discovery process. Anal Chem. 74:2002;1-9.
24. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470.
25. Huang F., Adelman J., Jiang H., Goldstein N.I., Fisher P.B. Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells. Oncogene. 18:1999;3546-3552.
26. Schena M., Heller R.A., Theriault T.P., Konrad K., Lachenmeier E., Davis R.W. Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol. 16:1998;301-306.
27. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
28. Shen R., Su Z.Z., Olsson C.A., Fisher P.B. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc. Natl. Acad. Sci. U.S.A. 92:1995;6778-6782.
29. Kang D.C., LaFrance R., Su Z.Z., Fisher P.B. Reciprocal subtraction differential RNA display: an efficient and rapid procedure for isolating differentially expressed gene sequences. Proc. Natl. Acad. Sci. U.S.A. 95:1998;13788-13793.
30. Zhang L., Zhou W., Velculescu V.E., Kern S.E., Hruban R.H., Hamilton S.R.et al. Gene expression profiles in normal and cancer cells. Science. 276:1997;1268-1272.
31. Jiang H., Kang D.C., Alexandre D., Fisher P.B. RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes. Proc. Natl. Acad. Sci. U.S.A. 97:2000;12684-12689.
32. Byers R.J., Hoyland J.A., Dixon J., Freemont A.J. Subtractive hybridization - genetic takeaways and the search for meaning. Int. J. Exp. Pathol. 81:2000;391-404.
33. Stassar M.J., Devitt G., Brosius M., Rinnab L., Prang J., Schradin T.et al. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br. J. Cancer. 85:2001;1372-1382.
34. Lisitsyn N.A., Lisitsina N.M., Dalbagni G., Barker P., Sanchez C.A., Gnarra J.et al. Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc. Natl. Acad. Sci. U.S.A. 92:1995;151-155.
35. Hubank M., Schatz D.G. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22:1994;5640-5648.
36. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science. 289:2000;1760-1763.
37. Kawahashi Y., Doi N., Takashima H., Tsuda C., Oishi Y., Oyama R.et al. In vitro protein microarrays for detecting protein-protein interactions: application of a new method for fluorescence labeling of proteins. Proteomics. 3:2003;1236-1243.
38. Lam K.S., Renil M. From combinatorial chemistry to chemical microarray. Curr. Opin. Chem. Biol. 6:2002;353-358.
39. Bauer A., Kuster B. Affinity purification-mass spectrometry. Powerful tools for the characterization of protein complexes. Eur. J. Biochem. 70:2003;570-578.
40. Zamore P.D., Tuschl T., Sharp P.A., Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 101:2000;25-33.
41. Elbashir S.M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15:2001;188-200.
42. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
43. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G.et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 419:2002;624-629.
44. Zambrowicz B.P., Friedrich G.A., Buxton E.C., Lilleberg S.L., Person C., Sands A.T. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature. 392:1998;608-611.
45. Lewis D.L., Hagstrom J.E., Loomis A.G., Wolff J.A., Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32:2002;107-108.
46. McCaffrey A.P., Meuse L., Pham T.T., Conklin D.S., Hannon G.J., Kay M.A. Gene expression: RNA interference in adult mice. Nature. 418:2002;38-39.
47. Xia H., Mao Q., Paulson H.L., Davidson B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20:2002;1006-1010.
48. Milligan G. High-content assays for ligand regulation of G-protein-coupled receptors. Drug Discov. Today. 8:2003;579-585.
49. Geysen H.M., Meloen R.H., Barteling S.J. Use of peptide synthesis to pobe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. U.S.A. 81:1984;3998-4002.
50. Makino S., Suzuki N., Nakanishi E., Tsuji T. Efficient solid-phase synthesis of quinazoline-2-thioxo-4-ones with SynPhase lanterns. Tetrahedron Lett. 41:2000;8333-8337.
51. Phoon C.W., Sim M.M. Traceless synthesis of urea, semicarbazide and carbamate derivatives using bromo-Wang resin and bromo-Wang SynPhase Lantern. Synlett. 5:2001;697-699.
52. Frank R. Spot-synthesis - an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron. 48:1992;9217-9232.
53. Nicolaou K.C., Xiao X.Y., Parandoosh Z., Senyei A., Nova M.P. Radiofrequency encoded combinatorial chemistry. Angew. Chem. Int. Ed. 34:1995;2289-2291.
54. Moran E.J., Sarshar S., Cargill J.F., Shahbaz M.M., Lio A., Mjalli A.M.M.et al. Radio frequency tag encoded combinatorial library method for the discovery of tripeptide-substituted cinnamic acid inhibitors of the protein tyrosine phosphatase Ptp1b. J. Am. Chem. Soc. 117:1995;10787-10788.
55. Liu R., Enstrom A.M., Lam K.S. Combinatorial peptide library methods for immunobiology research. Exp. Hematol. 31:2003;11-30.
56. Lam K.S. Application of combinatorial library methods in cancer research and drug discovery. Anti-Cancer Drug Design. 12:1997;145-167.
57. Weller H.N., Young M.G., Michalczyk S.J., Reitnauer G.H., Cooley R.S., Rahn P.C.et al. High throughput analysis and purification in support of automated parallel synthesis. Mol. Diversity. 3:1997;61-70.
58. Lam K.S., Salmon S.E., Hersh E.M., Hruby V.J., Kazmierski W.M., Knapp R.J. A new type of synthetic peptide library for identifying ligand-binding activity. Nature. 354:1991;82-84.
59. Czarnik A.W. Encoding methods for combinatorial chemistry. Curr. Opin. Chem. Biol. 1:1997;60-66.
60. Barnes C., Balasubramanian S. Recent developments in the encoding and deconvolution of combinatorial libraries. Curr. Opin. Chem. Biol. 4:2000;346-350.
61. Affleck R.L. Solutions for library encoding to create collections of discrete compounds. Curr. Opin. Chem. Biol. 5:2001;257-263.
62. Liu R., Marik J., Lam K.S. A novel peptide-based encoding system for "one-bead one-compound" peptidomimetic and small molecule combinatorial libraries. J. Am. Chem. Soc. 124:2002;7678-7680.
63. Song A., Zhang J., Lebrilla C.B., Lam K.S. A novel and rapid encoding method based on mass spectrometry for "one-bead-one-compound" small molecule combinatorial libraries. J. Am. Chem. Soc. 125:2003;6180-6188.
64. Blackwell H.E., Perez L., Schreiber S.L. Decoding products of diversity pathways from stock solutions derived from single polymeric macrobeads. Angew. Chem. Intl. Ed. 40:2001;3421-3425.
65. Marik J, Xu Q, Lam KS, Wang X, Peng L. A novel encoded high-density chemical micro-array platform for proteomics and drug development. In: Proceeding of the 18th American Peptide Symposium; 2004 [in press].
66. Krchnak K. Combinatorial chemistry encore technique. US Patent US 2002102611 (2002).
67. Lehn J.M., Eliseev A.V. Dynamic combinatorial chemistry. Science. 291:2001;2331-2332.
68. Erlanson D.A., Lam J.W., Wiesmann C., Luong T.N., Simmons R.L., DeLano W.L.et al. In situ assembly of enzyme inhibitors using extended tethering. Nat. Biotechnol. 21:2003;308-314.
69. Ramstrom O., Lehn J.-M. Drug discovery by dynamic combinatorial libraries. Nat. Rev. Drug Discov. 1:2002;26-36.
70. Fodor S.P.A., Read J.L., Pirrung M.C., Stryer L., Lu A.T., Solas D. Light-directed, spatially addressable parallel chemical synthesis. Science. 251:1991;767-773.
71. Falsey J.R., Renil M., Park S., Li S., Lam K.S. Peptide and small molecule microarray for high throughput cell adhesion and functional assays. Bioconjugate Chem. 12:2001;346-353.
72. Lam K.S., Liu R., Miyamoto S., Lehman A.L., Tuscano J.M. Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research. Acc. Chem. Res. 36:2003;370-377.
73. Lam K.S., Renil M. From combinatorial chemistry to chemical microarray. Curr. Opin. Chem. Biol. 6:2002;353-358.
74. Howbrook D.N., van der Valk A.M., O'Shaughnessy M.C., Sarker D.K., Baker S.C., Lloyd A.W. Developments in microarray technologies. Drug Discov. Today. 8:2003;642-651.
75. Walters W.P., Namchuk M. Designing screens: how to make your hits a hit. Nat. Rev. Drug Discov. 2:2003;259-266.
76. Arden S.R., Janardhan P., Debiasio R., Arnold B., Ghosh R.N. An automated quantitative high content sscreening assay for neurite outgrowth. Chimica Oggi. 20:2002;64-67.
77. Ohlmeyer M.H.J., Swanson R.N., Dillard L.W., Reader J.C., Asouline G., Kobayashi R.et al. Complex synthetic chemical libraries indexed with molecular tags. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10922-10926.
78. Ni Z.J., Maclean D., Holmes C.P., Murphy M.M., Ruhland B., Jacobs J.W.et al. Versatile approach to encoding combinatorial organic syntheses using chemically robust secondary amine tags. J. Med. Chem. 39:1996;1601-1608.
79. Fitch W.L., Baer T.A., Chen W., Holden F., Holmes C.P., Maclean D.et al. Improved methods for encoding and decoding dialkylamine-encoded combinatorial libraries. J. Comb. Chem. 1:1999;188-194.
80. Shchepinov M.S., Chalk R., Southern E.M. Trityl tags for encoding in combinatorial synthesis. Tetrahedron. 56:2000;2712-2724.
81. Salmon S.E., Liu-Stevens R.H., Zhao Y., Michal L., Viktor K., Ken W.et al. High-volume cellular screening for anticancer agents with combinatorial chemical libraries - a new methodology. Mol. Diversity. 2:1996;57-63.
82. Marron B., Jayawickreme C.K. Going to the well no more: lawn format assays for ultra-high-throughput screening. Curr. Opin. Chem. Biol. 7:2003;395-401.
83. Kick E.K., Roe D.C., Skillman A.G., Liu G., Ewing T.J.A., Sun Y.et al. Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D. Chem. Biol. 4:1997;297-307.
84. Bergstrom C.A.S., Strafford M., Lazorova L., Avdeef A., Luthman K., Artursson P. Absorption classification of oral drugs based on molecular surface properties. J. Med. Chem. 46:2003;558-570.
85. Walters W.P., Murcko M.A. Prediction of 'drug-likeness'. Adv. Drug Deliv. Rev. 54:2002;255-271.
86. Blundell T.L., Jhoti H., Abell C. High-throughput crystallography for lead discovery in drug design. Nat. Rev. Drug. Discov. 1:2002;45-54.
87. Stewart L., Clark P., Behnke C. High-throughput crystallization and structure determination in drug discovery. Drug Discov. Today. 7:2002;187-196.
88. Goodwill K.E., Tennant M.G., Stevens R.C. High-throughput X-ray crystallography for structure-based drug design. Drug Discov. Today. 6:2001;S113-S118.
89. Diercks T., Coles M., Kessler H. Applications of NMR in drug discovery. Curr. Opin. Chem. Biol. 5:2001;285-291.
90. Dalvit C., Flocco M., Knapp S., Mostardini M., Perego R., Stockman B.J. et al. High-throughput NMR-based screening with competition binding experiments. J. Am. Chem. Soc. 124:2002;7702-7709.
91. Shapiro M.J. Affinity NMR: a powerful method for drug discovery. Am. Pharma. Rev. 5:2002;9496-9497.
92. Martin V., Klaus F. NMR-based screening methods for lead discovery. EXS. 93:2003;183-202.
93. Hadjuk P.J., Gomtsyan A., Didomenico S., Cowart M., Bayburt E.K., Solomon L.et al. Design of adenosine kinase inhibitors from the NMR-based screening of fragments. J. Med. Chem. 43:2000;4781-4786.
94. Yates J.R. III Mass spectrometry and the age of the proteome. J. Mass Spectrom. 33:1998;1-19.